Landon C Brown (Landon Brown)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Prostate cancer and prostatic diseases

Journal for immunotherapy of cancer

JCO precision oncology

JCO oncology practice

Duke Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Duke Cancer Institute Jul 01 2018

United States

Fellow

Publications

Landon C Brown, Andrew J Armstrong
Germline Testing in Prostate Cancer: Implementation and Disparities of Care. JCO oncology practice (2023)
Landon C Brown, Jason Zhu, Elizabeth Mauer, Stephanie N Thiede, Lisa Macera, Michelle M Stein, Timothy Taxter, Derek Raghavan, Earle F Burgess
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer. JCO precision oncology 7 (2023)
Landon C Brown, Jason Zhu, Elizabeth Mauer, Stephanie N Thiede, Lisa Macera, Michelle M Stein, Timothy Taxter, Derek Raghavan, Earle F Burgess
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer. JCO precision oncology 7 (2023)
Landon C Brown, Jason Zhu, Kunal Desai, Emily Kinsey, Chester Kao, Yong Hee Lee, Sarabjot Pabla, Matthew Kyle Labriola, Jennifer Tran, Konstantin H Dragnev, Laura J Tafe, Farshid Dayyani, Rajan T Gupta, Shannon McCall, Daniel J George, Sean T Glenn, Mary K Nesline, Saby George, Matthew Zibelman, Carl Morrison, Moshe C Ornstein, Tian Zhang
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma. Journal for immunotherapy of cancer 10 (10) (2022)
Landon C Brown, Kunal Desai, Wei Wei, Emily N Kinsey, Chester Kao, Daniel J George, Brian I Rini, Moshe C Ornstein, Tian Zhang
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab. Journal for immunotherapy of cancer 9 (9) (2022)
Landon C Brown, Susan Halabi, Joseph D Schonhoft, Qian Yang, Jun Luo, David M Nanus, Paraskevi Giannakakou, Russell Z Szmulewitz, Daniel C Danila, Ethan S Barnett, Emily A Carbone, Jimmy L Zhao, Patrick Healy, Monika Anand, Audrey Gill, Adam Jendrisak, William L Berry, Santosh Gupta, Simon G Gregory, Richard Wenstrup, Emmanuel S Antonarakis, Daniel J George, Howard I Scher, Andrew J Armstrong
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Landon C Brown, Kunal B Desai, Tian Zhang, Moshe C Ornstein
The Immunotherapy Landscape in Renal Cell Carcinoma. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (6) (2021)
Landon C Brown, Matthew D Tucker, Ramy Sedhom, Eric B Schwartz, Jason Zhu, Chester Kao, Matthew Kyle Labriola, Rajan T Gupta, Daniele Marin, Yuan Wu, Santosh Gupta, Tian Zhang, Michael R Harrison, Daniel J George, Ajjai Alva, Emmanuel S Antonarakis, Andrew J Armstrong
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. Journal for immunotherapy of cancer 9 (3) (2021)
Vadim S Koshkin, Vaibhav G Patel, Alicia Ali, Mehmet A Bilen, Deepak Ravindranathan, Joseph J Park, Olesia Kellezi, Marcin Cieslik, Justin Shaya, Angelo Cabal, Landon C Brown, Matthew Labriola, Laura S Graham, Colin Pritchard, Abhishek Tripathi, Sanober Nusrat, Pedro Barata, Albert Jang, Shuang R Chen, Rohan Garje, Luna Acharya, Clara Hwang, Amanda Pilling, William K Oh, Tomi Jun, Divya Natesan, Chris Nguyen, Deepak Kilari, Michael Pierro, Bicky Thapa, Frank Cackowski, Alleda Mack, Elisabeth I Heath, Catherine H Marshall, Scott T Tagawa, Susan Halabi, Michael T Schweizer, Andrew J Armstrong, Tanya Barauskas Dorff, Ajjai Alva, Rana R McKay
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer. Prostate cancer and prostatic diseases (2021)
Kunal B Desai, Landon C Brown, Wei Wei, Matthew D Tucker, Chester Kao, Emily Kinsey, Brian Rini, Kathryn E Beckermann, Tian Zhang, Moshe C Ornstein
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab. Targeted oncology 16 (5) (2021)
Landon C Brown, Changxue Lu, Emmanuel S Antonarakis, Jun Luo, Andrew J Armstrong
Androgen receptor variant-driven prostate cancer II: advances in clinical investigation. Prostate cancer and prostatic diseases 23 (3) (2020)
Changxue Lu, Landon C Brown, Emmanuel S Antonarakis, Andrew J Armstrong, Jun Luo
Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations. Prostate cancer and prostatic diseases 23 (3) (2020)

Landon C Brown.css-eqlu8i{font-size:small;padding-left:4px;} (Landon Brown)

Publication Activity (10 Years)

Top Topics

Top Venues

Landon C Brown (Landon Brown)